ASLAN’s A4 webinar series: ‘Dialogues with International Thought Leaders in Dermatology’ featured a series of Key Opinion Leader (KOL) events on the emerging Atopic Dermatitis (AD) landscape and ASLAN004 (eblasakimab)
ASLAN’s A4 webinar series: ‘Dialogues with International Thought Leaders in Dermatology’ featured a series of Key Opinion Leader (KOL) events on the emerging Atopic Dermatitis (AD) landscape and ASLAN004 (eblasakimab)